HZ-A-018

N/A

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameHZ-A-018
Drug Alias NameHZ-A-018
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase BTK inhibitors
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsCentral Nervous System LymphomaChronic UrticariaThrombocytopenia +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHangzhou Yuzheng Pharmaceutical Technology Co LtdHeaZen Therapeutics Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHeaZen Therapeutics Co LtdHangzhou Yuzheng Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsCentral Nervous System LymphomaChronic UrticariaThrombocytopenia +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A